原发性肝癌射频消融术后胸腔积液的研究

Study of Pleural Effusion after Radiofrequency Ablation for Primary Hepatocellular Carcinoma

目的:探讨原发性肝癌射频消融术后胸腔积液形成的影响因素,从而更好的评估射频消融的安全性。方法:对45例采用一次性完全射频消融治疗的肝癌患者进行回顾性分析,根据肿瘤位置不同分为(靠近膈肌组,≤10 mm)A组和(远离膈肌组,>10 mm)B组,观察是否出现胸腔积液并进行统计学分析,从而判定肿瘤位置是否是影响射频消融术后胸腔积液出现与否的因素。结果:A组和B组射频术后胸腔积液的发生率有显著差异。结论:肿瘤位置是影响肝癌射频消融术后是否出现胸腔积液的重要因素。

Objective: To investigate the factors influencing the formation of pleural effusion in patients with primary liver cancer after radiofrequency ablation, and to evaluate the safety of RFA. Methods: We retrospectively reviewed 45 primary hepatic carcinoma patients who accepted one-off complete radiofrequency ablation (RFA). According to the tumor location, they were divided into group A (close to the diaphragm, less than 10 mm) and group B (away from the diaphragm, more than 10 mm). Then we observed whether pleural effusion occurred or not in each case. The outcomes were analyzed statistically to determine whether the location of the tumor affects the occurrence of pleural effusion after RFA or not. Results: There was a significant difference in the incidence of pleural effusion between group A and group B. Conclusion: The location of tumor is an important factor that affects the occurrence of pleural effusion after RFA for liver cancer.